by | Jun 29, 2024 | Publications
Nat Cancer. 2024 Jun 28. doi: 10.1038/s43018-024-00784-3. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a plasma cell malignancy of the bone marrow. Despite therapeutic advances, MM remains incurable, and better risk stratification as well as new therapies...
by | Jun 29, 2024 | Publications
Ann Hematol. 2024 Jun 28. doi: 10.1007/s00277-024-05860-3. Online ahead of print. ABSTRACT Multiple myeloma (MM) is a form of clonal plasma cell malignancy that associates with clinical manifestations such as anemia, hypercalcemia, bone pain, and renal impairment....
by | Jun 29, 2024 | Publications
Crit Rev Oncol Hematol. 2024 Jun 26:104429. doi: 10.1016/j.critrevonc.2024.104429. Online ahead of print. ABSTRACT In the intricate landscape of multiple myeloma, a hematologic malignancy of plasma cells, bone disease presents a pivotal and often debilitating...
by | Jun 28, 2024 | Publications
Medicine (Baltimore). 2024 Jun 28;103(26):e38609. doi: 10.1097/MD.0000000000038609. ABSTRACT Evidence on real-world clinical and economic outcomes in patients with multiple myeloma (MM) and renal impairment (RI) is limited in the United States. This retrospective...
by | Jun 28, 2024 | Publications
Medicine (Baltimore). 2024 Jun 28;103(26):e38541. doi: 10.1097/MD.0000000000038541. ABSTRACT INTRODUCTION: Multiple myeloma (MM) with extramedullary disease (EMD) is rare in clinical practice, and B cell maturation antigen (BCMA) CAR-T cell therapy is a novel therapy...
by | Jun 28, 2024 | Publications
Skeletal Radiol. 2024 Jun 28. doi: 10.1007/s00256-024-04735-y. Online ahead of print. ABSTRACT OBJECTIVE: Fatty infiltration of skeletal muscle (Myosteatosis) is associated with increased frailty, decreased muscle and mobility function, which seems fairly prevalent in...
